Allegheny General Hospital ( Site 0048) — Pittsburgh, Pennsylvania

Allegheny General Hospital ( Site 0048) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Allegheny General Hospital ( Site 0048) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allegheny General Hospital ( Site 0048)?

Allegheny General Hospital ( Site 0048) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allegheny General Hospital ( Site 0048) conducted?

Allegheny General Hospital ( Site 0048) has 2 clinical trials on record, with 2 currently active. Their work covers Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Is Allegheny General Hospital ( Site 0048) accredited by Crixeo Health?

Allegheny General Hospital ( Site 0048) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allegheny General Hospital ( Site 0048)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.